Hans-Peter Hasler
Chairman at SHIELD THERAPEUTICS PLC
Net worth: 2 M $ as of 2024-04-29
Network origin in Hans-Peter Hasler first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
118
| Public Company | Pharmaceuticals: Major | 118 |
27
| Extinct | Pharmaceuticals: Major | 27 |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Elan Corp. Plc is a neuroscience focused biotechnology company. The company engages in research, development, and commercial activities for neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease and autoimmune diseases, including multiple sclerosis. It was founded in December 1969 and is headquartered in Dublin, Ireland.
27
| Extinct | Pharmaceuticals: Major | 27 |
| Public Company | Pharmaceuticals: Major | 20 | |
| Subsidiary | Pharmaceuticals: Major | 19 | |
| Public Company | Pharmaceuticals: Major | 18 | |
| Public Company | Biotechnology | 15 | |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
| Public Company | Pharmaceuticals: Major | 11 | |
| Venture Capital Fund | Investment Managers | 10 | |
| Public Company | Pharmaceuticals: Major | 8 | |
Vicarius Pharma AG
 Vicarius Pharma AG Miscellaneous Commercial ServicesCommercial Services Vicarius Pharma AG provides research and development services for pharmaceutical, biotech, and medical companies. The private company is based in Zurich, Switzerland. The Swiss company was founded by Hans-Peter Hasler.
1
| Private Company | Miscellaneous Commercial Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Hans-Peter Hasler via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| BIOCRYST PHARMACEUTICALS, INC. | Biotechnology | Chairman Director of Finance/CFO | |
Biogen MA, Inc.
 Biogen MA, Inc. BiotechnologyHealth Technology Biogen MA, Inc. is a biotechnology company principally engaged in discovering and developing drugs for human healthcare through genetic engineering. The company’s research and development activities used to focus on novel products for multiple sclerosis, inflammatory, respiratory, kidney and cardiovascular diseases, developmental biology and gene therapy. The company was founded by Daniel D. Adams in 1976 and is headquartered in Cambridge, MA. | Biotechnology | Human Resources Officer Chief Tech/Sci/R&D Officer Director of Finance/CFO Corporate Officer/Principal | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| CELGENE | Biotechnology | Chief Executive Officer Director of Finance/CFO | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Operating Officer | |
Encysive Pharmaceuticals, Inc.
 Encysive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor Corporate Officer/Principal | |
Quintiles Transnational Corp.
 Quintiles Transnational Corp. Miscellaneous Commercial ServicesCommercial Services Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member President | |
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | General Counsel President | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Comptroller/Controller/Auditor Director/Board Member Chairman | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | President Director/Board Member Director/Board Member | |
| University of Notre Dame | College/University | Undergraduate Degree Corporate Officer/Principal | |
Viamet Pharmaceuticals, Inc.
 Viamet Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals, Inc. discovers and develops inhibitors of validated metalloenzymes. The firm's clinical portfolio includes novel agents to treat both chronic and life threatening fungal infections. It also leverage our metalloenzyme expertise in other therapeutic areas including oncology and orphan diseases. The company was founded by Thomas V. O’Halloran and Holden H. Thorp on August 18, 2005 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Elan Pharmaceuticals, LLC
 Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Chairman Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
| RECEPTOS INC | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| NVN LIQUIDATION, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer | |
Viamet Pharmaceuticals Corp.
 Viamet Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Viamet Pharmaceuticals Corp. engages in the discovery, development, and commercialization of novel pharmaceuticals based on its proprietary metalloenzyme chemistry and biology technology platform. Its clinical portfolio includes novel agents to treat chronic and life threatening fungal infections. Its products include VT-1161, an oral agent that treats onychomycosis; VT-1129, which treats cryptococcal meningitis; and VT-1598, that treats coccidioidomycosis. The company was founded by Herbert Holden Thorp and Thomas V. O'Halloran in December 2011 and is headquartered in Durham, NC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| MALIN CORPORATION PLC | Biotechnology | Director/Board Member Director/Board Member Chief Executive Officer Chairman Chairman Chairman | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Doctorate Degree Graduate Degree Graduate Degree | |
| Stanford University | College/University | Undergraduate Degree Masters Business Admin Undergraduate Degree | |
| UDG HEALTHCARE PLC | Miscellaneous Commercial Services | Director/Board Member Chairman Director of Finance/CFO | |
| University of California, Los Angeles | College/University | Doctorate Degree Graduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Director/Board Member Doctorate Degree Undergraduate Degree | |
| Yale University | College/University | Doctorate Degree Doctorate Degree | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University College Dublin | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Director of Finance/CFO General Counsel Comptroller/Controller/Auditor | |
| University of Basel | College/University | Graduate Degree Director/Board Member Graduate Degree Graduate Degree | |
| THERIVA BIOLOGICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Executive Officer | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Corporate Officer/Principal | |
Phosphate Therapeutics Ltd.
 Phosphate Therapeutics Ltd. BiotechnologyHealth Technology Phosphate Therapeutics Ltd. provides research and experimental development on biotechnology. It engages in development of drug named PT20 to cure high phosphate levels in blood. The company was founded in 2011 and is headquartered in Gateshead Quays, the United Kingdom. | Biotechnology | Chief Executive Officer Director/Board Member | |
| PROTHENA CORPORATION PLC | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Prothena Biosciences, Inc.
 Prothena Biosciences, Inc. BiotechnologyHealth Technology Part of Prothena Corp. Plc, Prothena Biosciences, Inc. is a company that specializes in the biology of misfolded proteins. The company is based in South San Francisco, CA. The company has over 3 decades of expertise in this field and offer a range of services including science, pipeline, clinical trial information, and more. | Biotechnology | Director/Board Member Chairman | |
DPx Holdings BV
 DPx Holdings BV Drugstore ChainsRetail Trade DPx Holdings BV provides pharmaceutical services, fine chemicals and proprietary products and technologies. It operates business through three business unites which include Patheon, DSM Fine Chemicals and Banner Life Sciences. Patheon consists of pharmaceutical services, which include commercial manufacturing capabilities, pharmaceutical development services, as well as the biologics and biosolutions businesses; DSM Fine Chemicals includes active pharmaceutical ingredients services as well as the ES/IM business offer is primarily comprised of agricultural and crop protection chemicals and specialty intermediates; and Banner Life Sciences serves the needs of the proprietary products business and will now include additional brands from DPP. The company has offices in Australia, Europe, Latin America and North America. DPx Holdings was founded in March 2014 and is headquartered in Framingham, MA. | Drugstore Chains | Public Communications Contact Chief Executive Officer Director of Finance/CFO | |
| POSEIDA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
| NEXTCURE, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
GT Gain Therapeutics SA
 GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology GT Gain Therapeutics SA operates as a preclinical stage biotech firm developing a class of next generation brain-penetrant non-competitive pharmacological chaperones for the treatment of devastating diseases using the proprietary SEE-Tx technology. Its projects include Beta-galactosidase GLB1 gene and Glucosylceramidase GBA gene. The company was founded by Lorenzo Leoni and is headquartered in Lugano, Switzerland. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chairman Corporate Officer/Principal | |
| IMMUNOCORE HOLDINGS PLC | Biotechnology | Director/Board Member Director/Board Member | |
| ALKERMES PLC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Prothena Therapeutics Ltd.
 Prothena Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Prothena Corp. Plc, Prothena Therapeutics Ltd. is an Irish nonprofit company located in Dublin that provides business services. | Miscellaneous Commercial Services | Director/Board Member Private Equity Investor | |
Serenus Biotherapeutics, Inc.
 Serenus Biotherapeutics, Inc. Medical DistributorsDistribution Services Serenus Biotherapeutics, Inc. distributes and manufactures pharmaceutical drug products. The company is headquartered in San Francisco, CA. | Medical Distributors | Chairman Founder |
Statistics
International
| United States | 35 |
| Ireland | 8 |
| United Kingdom | 6 |
| Switzerland | 4 |
| Canada | 2 |
Sectoral
| Health Technology | 34 |
| Consumer Services | 10 |
| Commercial Services | 6 |
| Finance | 2 |
| Retail Trade | 2 |
Operational
| Director/Board Member | 649 |
| Corporate Officer/Principal | 220 |
| Independent Dir/Board Member | 205 |
| Chairman | 166 |
| Chief Executive Officer | 110 |
Most connected contacts
| Insiders | |
|---|---|
| Robert Alexander Ingram | 43 |
| Elaine Jones | 37 |
| Paul Gary Kennedy | 33 |
| William Young | 32 |
| Patrick Kennedy | 30 |
| Prasad Raghava Menon | 29 |
| Khalid Islam | 29 |
| Dov Goldstein | 28 |
| Rolf K. Hoffmann | 27 |
| Stelios Papadopoulos | 26 |
| Marc Beer | 25 |
| Sylvie Grégoire | 25 |
| Robert Ruffolo | 24 |
| William Rastetter | 24 |
| Michael Lytton | 24 |
- Stock Market
- Insiders
- Hans-Peter Hasler
- Company connections